Doxazosin Tablet
Product Images NDC 71610-628

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71610-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 8 mg (71610 0628 60)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Doxazosin 01

FDA Label Image

Doxazosin 02

Doxazosin 02
The text provides a summary of effectiveness data in placebo-controlled trials for the treatment of BPH symptoms with CARDURA. The data obtained from three studies including maximum flow rate, symptom score, etc. The study concludes that CARDURA was more effective than placebo in reducing BPH symptoms.*
FDA Label Image

Doxazosin 03

FDA Label Image

Doxazosin 04

Doxazosin 04
This text represents information about the distribution of Greenstone branded products by Greenstone LLC, located in Peapack, NJ 07977.*
FDA Label Image

Doxazosin 04a

Doxazosin 04a
This is a description of a pharmaceutical brand named "GREENSTONE® BRAND" that is distributed by Greenstone LLC located in Peapack, NJ 07977.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.